Skip to main content

Advertisement

SpringerLink
Log in

Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP

  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

Lung cancer remains one of the most common causes of cancer-related death worldwide. Approximately 80% is histologically non-small cell lung carcinoma (NSCLC) and in about 70% of patients it is an unresectable type. Clinical studies indicated that application of platinum derivatives caused good results and combinations of platinum with other agents could improve median survivals. In view of the central problem of sufficient efficiency of drugs in chemotherapy, efforts have focused on the development of alternative platinum-based analogues that can be more effective in cancer treatment. cis-bis(3-aminoflavone)dichloroplatinum(II) (cis-Pt(II) complex of 3-aminoflavone) represents a novel class of platinum-based potential antitumour agents. In order to evaluate the degree of apoptosis, acridine orange/ethidium bromide and Hoechst 33258/propidum iodide double staining as well as RT-PCR (P53 and BAX expression evaluation) were used in lung cancer cell line A549 after treatment with this compound in comparison with cis-diamminedichloroplatinum(II) (cis-DDP). Apoptotic cells at early and late stages and also necrotic ones were observed after usage of cis-Pt(II) complex of 3-aminoflavone and the percentage of these cells outnumbered the values obtained after cis-DDP application. The former compound induced a higher percentage of P53 and BAX expression in A549 cells in comparison with the latter one. Results indicate the beneficial properties of cis-Pt(II) complex of 3-aminoflavone as a potential antitumor drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dancey J, Le Chevalier T: Non-small cell lung cancer: An overview of current management. Eur J Cancer 33: S2–S7, 1997

    Article  PubMed  Google Scholar 

  2. Borner MM, Joncourt F, Hotz MA: Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells. Br J Cancer 76: 1448–1454, 1997

    PubMed  Google Scholar 

  3. Siemer S, Ørnskov D, Guerra B, Boldyreff B, Issinger O-G: Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. Int J Biochem & Cell Biol 31: 661–670, 1999

    Google Scholar 

  4. Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI: Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol Pharmacol 57: 503–511, 2000

    PubMed  Google Scholar 

  5. Choi JH, Ahn KS, Kim J, Hong YS: Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer. Exp Mol Medicine 32: 23–28, 2000

    Google Scholar 

  6. Hagopian GS, Mills GB, Khokhar AR, Bast Jr. RC, Siddik ZH: Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the novel Platinum Analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Cancer Res 5: 655–663, 1999

    Google Scholar 

  7. Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig W-D, Henze G, Dörken B, Daniel PT: Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 14: 1606–1613, 2000

    Article  PubMed  Google Scholar 

  8. Kawakami K, Tsukuda M, Mizuno H, Nishimura G, Ishii A, Hamajima K: Alteration of the Bcl-2/Bax Status of Head and Neck Cancer Cell Lines by Chemotherapeutic Agents. Anticancer Research 19: 3927–3932, 1999

    PubMed  Google Scholar 

  9. Fan J, Bertino JR: Modulation of cisplatinum cytotoxicity by p53: effect of p53-mediated apoptosis and DNA repair. Mol Pharmacol 56: 966–972, 1999

    PubMed  Google Scholar 

  10. Edelman M, Quam H, Mullins B: Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines. Cancer Chemother Pharmacol 48: 141–144, 2001

    Article  PubMed  Google Scholar 

  11. Nijveldt RJ, Nood E, Hoorn DEC, Boelens PG, Norren K, Leeuwen PAM: Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418–425, 2001

    PubMed  Google Scholar 

  12. Zyner E, Erxleben A, Ochocki J, Lippert B: Cu(II) complex of 3-aminoflavone. VII International Symposium on Inorganic Biochemistry 51, 2001

  13. Zyner E, Graczyk J, Ochocki J: Pt(II) and Pd(II) complexes of 3-aminoflavone: In vitro and in vivo evaluation. Pharmazie 54: 945–946, 1999

    PubMed  Google Scholar 

  14. Ochocki J, Zyner E. Patent Nr P.185585, 2003

  15. Lieberthal W, Triaca V, Levine J: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am Physiol Soc 3: F700–08, 1996

    Google Scholar 

  16. Leite M, Quinta-Costa M, Leite PS, Guimarães JS: Critical evaluation of techniques to detect and measure cell death—studey in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol 19: 139–151, 1999

    PubMed  Google Scholar 

  17. Vermes I, Haanen C, Reutelingsperger C: Flow cytometry of apoptotic cell death. J Immunol Methods 243: 167–190, 2000

    Article  PubMed  Google Scholar 

  18. Elstein KH, Zucker RM: Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 211: 322–331, 1994

    Article  PubMed  Google Scholar 

  19. Gasiorowski K, Brokos B, Kulma A, Ogorzalek A, Skorkowska K: A comparison of the methods applied to detect apoptosis in genotoxically-damaged lymphocytes cultured in the presence of four antimutagens. Cell Mol Biol Let 6: 141–159, 2001

    Google Scholar 

  20. Anan K, Morisaki T, Katano M, Ikubo A, Tsukahara Y, Kojima M, Uchiyama A, Kuroki S, Torisu M, Tanaka M: Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: Preoperative determination of malignant potential. Eur J Surg Oncol 24: 28–33, 1998

    Article  PubMed  Google Scholar 

  21. Schottelius A, Brennscheidt U, Ludwig W-D, Mertelsmann RH, Herrmann F, Lübbert M: Mechanisms of p53 alteration in acute leukemias. Leukemia 8: 1673–1681, 1994

    PubMed  Google Scholar 

  22. Mori S, Murakami-Mori K, Jewett A, Nakamura S, Bonavida B: Resistance of AIDS-associated Kaposi’s sarcoma cells to Fas-mediated apoptosis. Cancer Res 56: 1874–1879, 1996

    PubMed  Google Scholar 

  23. Wang T, Phang T: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487–2489, 1995

    PubMed  Google Scholar 

  24. Bueso-Ramos C-E, Yang Y, DeLeon E, McCown P, Stass SA, Albitar M: The human MDM-2 oncogene is overexpressed in leukemias Blood 82: 2617–2623, 1993

    PubMed  Google Scholar 

  25. Strobel T, Swanson L, Korsmeyer S, Cannistra SA: BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci 93: 14094–14099, 1996

    Article  PubMed  Google Scholar 

  26. Lam V, McPherson JP, Salmena L, Lees J, Chu W, Sexsmith E, Hedley DW, Freedman MH, Reed JC, Malkin D, Goldenberg GJ: p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leukemia Res 23: 871–880, 1999

    Article  Google Scholar 

  27. Tsuruta Y, Mandai M, Konishi I, Kuroda H, Kusakari T, Yyra Y, Hamid AA, Tamura I, Kariya M, Fujii S: Combination effect of adenovirus-mediated pro-apoptotic baxgene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. Eur J Cancer 37: 531–541, 2001

    Article  PubMed  Google Scholar 

  28. Lee RH, Song JM, Park MY, Kang SK, Kim UK, Jung JS: Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 62: 1013–1023, 2001

    Article  PubMed  Google Scholar 

  29. Racz I, Tory K, Gallyas F, Berente Z, Osz E, Jaszlits L, Bernath S, Sumegi B, Rabloczky G, Literati-Nagy P: BGP-15—a novel poly(ADP-ribose) polymerase inhibitor—protects against nephotoxicity of cisplatin without compromising its antitumor activity. Biochem Pharmacol 63: 1099–1011, 2002

    Google Scholar 

  30. Kelland LR: Preclinical perspectives on platinum resistance. Drugs 59: 1–8, 2000

    Google Scholar 

  31. Reedijk J: Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell? Chem Rev 99: 2499–2510, 1999

    Google Scholar 

  32. Zhang K, Chew M, Yang EB, Wong KP, Mack P: Modulation of cisplatin cytotoxicty and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 59: 837–843, 2001

    PubMed  Google Scholar 

  33. Lippert B: Cisplatin: Chemistry and Biochemistry of a leading anticancer drug. Zürich, Verlag, Helv. Chim. Acta., Wiley-VCH, Weinheim, 1999

  34. Järvinen K, Pietarinen-Runtti P, Linnainmaa K, Raivio KO, Krejsa CM, Kavanagh T, Kinnula VL: Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 278: L696–L702, 2000

    PubMed  Google Scholar 

  35. Kosmider B,Zyner E, Osiecka R, Ochocki J: Genotoxicity of cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP in A549 cells evaluated by the comet assay. Can J Physiol Pharmacol 82: 353–8, 2004

    Article  PubMed  Google Scholar 

  36. Kosmider B, Osiecka R, Zyner E, Ochocki J: Comparison between the genotoxicity of cis-Pt(II) complex of 3-aminoflavone and cis-DDP in lymphocytes evaluated by the comet assay. Drug Chem Toxicol 28: 231–244, 2005

    PubMed  Google Scholar 

  37. Ciesielska E, Studzian K, Zyner E, Ochocki J, Szmigiero L: DNA damage and apoptosis induction in L1210 cells by cis-diamminedichloroplatinum (II) and its new aminoflavone analogue. Cell Mol Biol Let 5: 441–450, 2000

    Google Scholar 

  38. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y, Sakai T: Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Letters 437: 61–64, 1998

    Article  PubMed  Google Scholar 

  39. Priya SD, Devi CSS: Protective effect of quercetin in cisplatin-induced cell injury in the rat kidney. Indian J Pharmacol 31: 422–426, 1999

    Google Scholar 

  40. Weijl NI, Clenton FJ, Osanto S: Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Reviews 23: 209–240, 1997

    Article  PubMed  Google Scholar 

  41. Kosmider B, Wyszynska K, Janik-Spiechowicz E, Osiecka R, Zyner E, Ochocki J, Ciesielska E, Wasowicz W: Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP. Mutat Res 558: 93–110, 2004

    PubMed  Google Scholar 

  42. Kosmider B, Osiecka R, Ciesielska E, Szmigiero L, Zyner E, Ochocki J: Induction of apoptosis and necrosis in lymphocytes by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 558: 169–179, 2004

    PubMed  Google Scholar 

  43. Kosmider B, Zyner E, Osiecka R, Ochocki J: Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 563: 61–70, 2004

    PubMed  Google Scholar 

  44. Kosmider B, Osiecka R: Flavonoid compounds: A review of anticancer properties and interactions with cis-diamminedichloro- platinum(II). Drug Develop Res 63: 200–211, 2004

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cytogenetics and Plant Molecular Biology, University of Lodz, ul. Banacha 12/16, 90-237, Lodz, Poland

    Beata Kosmider & Regina Osiecka

  2. Department of Oncology, Medical University, ul. Czechoslowacka 8/10, 92-216, Lodz, Poland

    Izabela Wojcik & Pawel Liberski

  3. Department of Medical Biochemistry, Medical University, ul. Mazowiecka 6/8, 92-215, Lodz, Poland

    Jacek Bartkowiak

  4. Department of Bioinorganic Chemistry, Medical University, ul. Muszynskiego 1, 90-151, Lodz, Poland

    Elzbieta Zyner & Justyn Ochocki

Authors
  1. Beata Kosmider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Izabela Wojcik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Regina Osiecka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacek Bartkowiak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elzbieta Zyner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Justyn Ochocki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pawel Liberski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kosmider, B., Wojcik, I., Osiecka, R. et al. Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Invest New Drugs 23, 287–297 (2005). https://doi.org/10.1007/s10637-005-1437-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-005-1437-z

Keywords

Search

Navigation